1. Cholesterol ester storage disease in an adult presenting with sea-blue histiocytosis.
- Author
-
Besley GT, Broadhead DM, Lawlor E, McCann SR, Dempsey JD, Drury MI, and Crowe J
- Subjects
- Adult, Cells, Cultured, Chromatography, Thin Layer, Fibroblasts metabolism, Humans, Lipid Metabolism, Inborn Errors drug therapy, Lipid Metabolism, Inborn Errors pathology, Liver metabolism, Liver pathology, Male, Phenobarbital therapeutic use, Sea-Blue Histiocyte Syndrome drug therapy, Sea-Blue Histiocyte Syndrome pathology, Skin metabolism, Skin pathology, Triglycerides metabolism, Cholesterol Esters metabolism, Lipid Metabolism, Inborn Errors metabolism, Naphthol AS D Esterase deficiency, Sea-Blue Histiocyte Syndrome metabolism
- Abstract
An adult patient is described with hepatomegaly and sea-blue histiocytes in the bone marrow. A diagnosis of cholesterol ester storage disease was established following enzyme and lipid analyses on liver biopsy and cultured skin fibroblasts. Acid esterase activity was deficient (approx. 5% of controls) in liver and fibroblasts using [14C]-triolein or 4-methylumbelliferyl palmitate as substrates. Cholesterol ester levels were raised about 70-fold in liver, whereas triglyceride levels were only marginally raised. Marked accumulation of cholesterol esters was also demonstrated in cultured fibroblasts. Clinically, the patient responded favourably to phenobarbitone treatment. However, this was not reflected in liver acid esterase or lipid levels.
- Published
- 1984
- Full Text
- View/download PDF